Pathogen-mediated inflammatory atherosclerosis is mediated in part via toll-like receptor 2-induced inflammatory responses

Journal of Innate Immunity

Volumn 2, Issue 4, 2010, Pages 334-343

  Hayashi, Chie ^a   Madrigal, Andres G ^a   Liu, Xinyan ^a   Ukai, Takashi ^a   Goswami, Sulip ^a   Gudino, Cynthia V ^a   Gibson III, Frank C ^a   Genco, Caroline A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Inflammation; Porphyromonas gingivalis; Pro inflammatory cytokines; Toll like receptor 2

Indexed keywords

APOLIPOPROTEIN E; AUTACOID; CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BACTEROIDACEAE INFECTION; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BACTEROIDACEAE INFECTIONS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PORPHYROMONAS GINGIVALIS; TOLL-LIKE RECEPTOR 2;

EID: 77954046821     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000314686     Document Type: Article

References (38)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
2. Kleemann R, Zadelaar S, Kooistra T: Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008; 79: 360-376.
3. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621.
4. Akira S: TLR signaling, Curr Top Microbiol Immunol 2006; 311: 1-16. (Pubitemid 47413193)
5. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ: Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105: 1158-1161. (Pubitemid 34225814)
6. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW: Reduced atherosclerosis in MyD88- null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004; 10: 416-421. (Pubitemid 38508522)
7. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M: Lack of Toll-like receptor or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004; 101: 10679-10684. (Pubitemid 38955802)
8. Mullick AE, Tobias PS, Curtiss LK: Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005; 115: 3149-3156.
9. Rekhter M, Staschke K, Estridge T, Rutherford P, Jackson N, Gifford-Moore D, Foxworthy P, Reidy C, Huang XD, Kalbfleisch M, Hui K, Kuo MS, Gilmour RVlahos CJ: Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation. Biochem Biophys Res Commun 2008; 367: 642-648.
10. Belland RJ, Ouellette SP, Gieffers J, Byrne GI: Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 2004; 6: 117-127. (Pubitemid 38111593)
11. Gibson FC, 3rd, Yumoto H, Takahashi Y, Chou HH, Genco CA: Innate immune signaling and Porphyromonas gingivalis -accelerated atherosclerosis. J Dent Res 2006; 85: 106-121. (Pubitemid 43827742)
12. Gibson FC, 3rd, Ukai T, Genco CA: Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front Biosci 2008; 13: 2041-2059. (Pubitemid 351589233)
13. Pihlstrom BL, Michalowicz BS, Johnson NW: Periodontal diseases. Lancet 2005; 366: 1809-1820.
14. Schoneveld AH, Oude Nijhuis MM, van Middelaar B, Laman JD, de Kleijn DP, Pasterkamp G: Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res 2005; 66: 162-169. (Pubitemid 40357879)
15. Burns E, Bachrach G, Shapira L, Nussbaum G: Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 2006; 177: 8296-8300. (Pubitemid 44893789)
16. Liu X, Ukai T, Yumoto H, Davey M, Goswami S, Gibson FC 3rd, Genco CA: Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis 2008; 196: 146-154.
17. Gibson FC, 3rd, Genco CA: Prevention of Porphyromonas gingivalis -induced oral bone loss following immunization with gingipain R1. Infect Immun 2001; 69: 7959-7963.
18. Reddy AB, Srivastava SK, Ramana KV: Antiinflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis. Cytokine 2009.
19. Li L, Messas E, Batista EL, Jr., Levine RA, Amar S: Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002; 105: 861-867. (Pubitemid 34174928)
20. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14: 133-140. (Pubitemid 24028177)
21. Shah PK, Nilsson J, Kaul S, Fishbein MC, Ageland H, Hamsten A, Johansson J, Karpe F, Cercek B: Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation 1998; 97: 780-785. (Pubitemid 28135341)
22. Gibson FC, 3rd, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA: Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004; 109: 2801-2806. (Pubitemid 38737928)
23. Davey M, Liu X, Ukai T, Jain V, Gudino C, Gibson FC 3rd, Golenbock D, Visintin A, Genco CA: Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs J Immunol 2008; 180: 2187-2195.
24. Naiki Y, Sorrentino R, Wong MH, Michelsen KS, Shimada K, Chen S, Yilmaz A, Slepenkin A, Schroder NW, Crother TR, Bulut Y, Doherty TM, Bradley M, Shaposhnik Z, Peterson EM, Tontonoz P, Shah PK, Arditi M: TLR/MyD88 and liver X receptorα signaling pathways reciprocally control Chlamydia pneumoniae -induced acceleration of atherosclerosis. J Immunol 2008; 181: 7176-7185.
25. Phipps RP: Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 2000; 97: 6930-6932.
26. Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Carr JJ, Rich SS, Freedman BI, Herrington DBowden DW: Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J 2006; 151: 706-711.
27. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C: IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997; 99: 2752-2761. (Pubitemid 27259823)
28. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC: Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999; 99: 861-866. (Pubitemid 29094297)
29. Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, Wilson TG, Jr., Higginbottom FL, Duff GW: The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24: 72-77.
30. Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, Pelli G, James RW, Mach F, Gabay C: Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 2005; 66: 583-593. (Pubitemid 40725770)
31. Chi H, Messas E, Levine RA, Graves DT, Amar S: Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation 2004; 110: 1678-1685. (Pubitemid 39297993)
32. Lalla E, Lamster IB, Hofmann MA, Bu cciarelli L, Jerud AP, Tucker S, Lu Y, Papapanou PN, Schmidt AM: Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003; 23: 1405-1411. (Pubitemid 36994529)
33. Wiley SR, Goodwin RG, Smith CA: Reverse signaling via CD30 ligand. J Immunol 1996; 157: 3635-3639.
34. Takahashi Y, Davey M, Yumoto H, Gibson FC 3rd, Genco CA: Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell Microbiol 2006; 8: 738-757.
35. Miyamoto T, Yumoto H, Takahashi Y, Davey M, Gibson FC 3rd, Genco CA: Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization. Infect Immun 2006; 74: 1376-1380. (Pubitemid 43185578)
36. Yumoto H, Chou HH, Takahashi Y, Davey M, Gibson FC 3rd, Genco CA: Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect Immun 2005; 73: 8050-8059. (Pubitemid 41740292)
37. Zhou X, Paulsson G, Stemme S, Hansson GK: Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo Eknockout mice. J Clin Invest 1998; 101: 1717-1725. (Pubitemid 28198502)
38. Madan M, Amar S: Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings. PLoS ONE 2008; 3:e3204.